CMIC Group / CMIC Shiftzero
CMIC/CMIC ShiftZero offers solutions for the entire lifecycle of the oncology products in Japan/Asia.
Our specialized team will support you with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology. Our resources, with an established network of Key Opinion Leaders (KOLs) in solid tumors and hematologic malignancies, will navigate the regulatory hurdles and accelerate your clinical trials by making the right connections.